HIPK2 and neoplasm: We confirm the loss of viability in vitro by e8-siRNA#1 (Hipk2 siRNA#2 in Kurokawa et al.)and further show its ability to efficiently reduce the growth of CSC-derived tumor xenografts in vivo.